Similar articles

• MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.

  Bruchez A, Sha K, Johnson J, Chen L, Stefani C, McConnell H, Gaucherand L, Prins R, Matreyek KA, Hume AJ, Mühlberger E, Schmidt EV, Olinger GG, Stuart LM, Lacy-Hulbert A. Bruchez A, et al. Science. 2020 Oct 9;370(6513):241-247. doi: 10.1126/science.abb3753. Epub 2020 Aug 27. Science. 2020. PMID: 32855215 Free PMC article.
• Ebola prepared these countries for coronavirus - but now even they are floundering.

  Maxmen A. Maxmen A. Nature. 2020 Jul;583(7818):667-668. doi: 10.1038/d41586-020-02173-z. Nature. 2020. PMID: 32694873 No abstract available.
• Adapting Ebola training to educate healthcare workers during the SARS-2-CoV pandemic.

  MenkinSmith L, Catchpole K, Reves JG. MenkinSmith L, et al. Am J Disaster Med. 2020 Spring;15(2):137-140. doi: 10.5055/ajdm.2020.0363. Am J Disaster Med. 2020. PMID: 32804393 No abstract available.
• Targeting the sAC-Dependent cAMP Pool to Prevent SARS-Cov-2 Infection.

  Aslam M, Ladilov Y. Aslam M, et al. Cells. 2020 Aug 25;9(9):1962. doi: 10.3390/cells9091962. Cells. 2020. PMID: 32854430 Free PMC article. Review.
• Class II transactivator: mastering the art of major histocompatibility complex expression.

  Harton JA, Ting JP. Harton JA, et al. Mol Cell Biol. 2000 Sep;20(17):6185-94. doi: 10.1128/MCB.20.17.6185-6194.2000. Mol Cell Biol. 2000. PMID: 10938095 Free PMC article. Review. No abstract available.